NCT05977218 DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial
| NCT ID | NCT05977218 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Linkoeping University |
| Condition | Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 900 participants |
| Start Date | 2025-08-25 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 900 participants in total. It began in 2025-08-25 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial will assess the impact of the FoodSwitch mobile app, which provides interpretive front-of-pack labelling via barcode scanning, in 900 Swedish adults with type 2 diabetes. Participants will be randomized to app + standard advice or standard advice alone. The primary outcome is change in HbA1c at 6 months; secondary outcomes include anthropometrics, quality of life, medication use, hospitalizations, and mortality.
Eligibility Criteria
Inclusion criteria: * Age between 18 and 75 years * Self-reported type 2 diabetes with a duration of ≥2 years * Regularly grocery shopping Exclusion criteria: * No access to BankID (a digital identification system commonly used in Sweden) * Failure to complete eligibility screening and run-in periods
Contact & Investigator
Karin Rådholm, MD, PhD
STUDY DIRECTOR
Linkoeping University
Frequently Asked Questions
Who can join the NCT05977218 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05977218 currently recruiting?
Yes, NCT05977218 is actively recruiting participants. Contact the research team at lana.hebib@liu.se for enrollment information.
Where is the NCT05977218 trial being conducted?
This trial is being conducted at Linköping, Sweden.
Who is sponsoring the NCT05977218 clinical trial?
NCT05977218 is sponsored by Linkoeping University. The principal investigator is Karin Rådholm, MD, PhD at Linkoeping University. The trial plans to enroll 900 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.